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Abstract 
The tumor microenvironment (TME) is a complex combination of stromal cells and extracellular 
matrix. The cancer-associated fibroblast (CAF) plays an integral role in remodeling the TME and 
promoting tumor aggression.  In this study, we present a 3D microfluidic model of the tumor 
stroma, which consists of a single straight micro-channel filled with CAF-embedded or acellular 
collagen gels.  Using this platform, we can quantify both fiber alignment and hydraulic 
permeability within the collagen matrix.  These results provide an enhanced understanding of the 
CAF’s influence on the TME, and this knowledge is critical to the development of more effective 
cancer treatments.  First, this study shows that genetic silencing of phosphatase and tensin homolog 
(PTEN) in CAFs causes a significant decrease in hydraulic permeability.  Moreover, this change 
occurs without physical reorientation of the collagen fibers, thereby suggesting that PTEN deleted 
CAFs may be secreting molecules – hypothesized to be hyaluronan – into the TME to cause this 
observed effect.  Using our microsystem as a drug screening platform, we also (1) identify the 
application of hyaluronidase and the inhibition of p-AKT as promising methods for mitigating the 
adverse effects of PTEN deletion and (2) show that GDC-0449 undesirably decreases the hydraulic 
permeability of the TME.  Finally, we have also utilized our microsystems to measure the 
properties of various acellular ECM gel compositions and compared these results to our CAF data. 
Our findings suggest that HA supplementation to collagen gels does not have an equivalent effect 
on matrix architecture as CAF-secreted HA. Overall, this study demonstrates the utility of our 
microfluidic model for studying the TME and provides key insights for developing more effective 
cancer treatments. 
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Introduction 
The Tumor Microenvironment and Cancer-Associated Fibroblasts 
Tumors can be considered as complex organs containing numerous highly specialized cell types. 
In solid tumors, the non-cancer cells and their surrounding extracellular matrix (ECM) combine to 
form what is known as the tumor microenvironment (TME) – which plays a critical role in 
regulating disease progression1.  Often, stromal cell types found in the TME exhibit abnormal 
behaviors that contribute to cancer aggression1,2; the particular cell type focused on in this study 
is the cancer-associated fibroblast (CAF). 
 The CAF is one of the most dominant and abundant cell types found in the TME.  Normal 
tissue associated fibroblasts are often charged with the role of secreting ECM to regulate 
inflammation and the wound-healing process.  However, CAFs display an activated state 
characterized by excessive secretion of ECM components and extreme remodeling of the 
surrounding environment2.  Previous studies have illustrated the significance of CAFs in cancer. 
For instance, in vitro experimentation has shown that CAF presence can stimulate the invasion of 
normally non-invasive cancer cells through Matrigel3. 
 Moreover, our collaborators have investigated the effect of phosphatase and tensin 
homolog (PTEN) – a known tumor suppressor – in CAFs.  In their study, cancer cells and CAFs 
were co-injected into mouse models to stimulate tumor formation.  This study showed that CAFs 
with genetically silenced PTEN expression resulted in increased rates of tumor progression and 
growth.  Furthermore, enhanced ECM and cytokine production was seen in the PTEN deleted CAF 
condition4. Here we further investigate the role of stromal PTEN in regulating cancer progression. 
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Aberrant Microenvironmental Properties in Cancer 
As cancer progresses, the TME is remodeled to exhibit abnormal properties that contribute to the 
metastatic potency and therapeutic resistance of tumors. Collagen fiber alignment has been 
identified as a hallmark of many invasive cancers5.  The oriented fiber structure surrounding 
tumors has been shown to guide migration and promote intravasation of cancer cells6.  In an in 
vitro study, fiber alignment was found to increase cancer cell motility through the ECM7. In our 
study, we explore whether CAFs within our microfluidic system reorganize collagen fibers into a 
more aligned structure. 
Additionally, therapeutic resistance in tumors is developed in part by the compression of 
vasculature.  In the TME, matrix components are secreted rapidly and abundantly leading to an 
increase in solid stress.  Consequently, this occurrence leads to the collapse of tumor blood vessels 
and the reduction of blood flow into the tumor8.  Hyaluronan or hyaluronic acid (HA) is a 
glycosaminoglycan  whose expression increases as cancer progresses9.  Due to its high negative 
charge density, HA can absorb water and swell within the microenvironment.  We hypothesize 
that this swelling will obstruct collagen pores within the TME and lead to decreased hydraulic 
permeability – the ability for fluid to flow through a porous matrix.  For clinical applications, 
decreased hydraulic permeability may be particularly problematic by lowering drug penetration 
into the tumor. 
Within the TME, collagen fibers can crosslink to form dense fibrotic tissue.  During this 
process, the ECM may stiffen to form a barrier to flow within the tumor; this occurrence is believed 
to also decrease hydraulic permeability10 and cause similar problems to what was previously 
discussed for HA. 
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Potential Impact and Experimental Motivation 
This study works with CAFs taken from patients with pancreatic ductal adenocarcinoma (PDAC) 
which is one of the most lethal cancer types. PDAC has a 5-year survival rate of less than 5%, and 
little progress has been made to improve patient outcomes in recent years11.  Over 90% of new 
therapeutics fail in clinical trials9, and many of these failures stem from a poor understanding of 
the TME.  The overall goals of this study are (1) to investigate specific CAF-induced 
microenvironmental changes that promote cancer aggression and (2) to explore stromal targeted 
therapies to combat tumor growth. 
 Specifically, in this study, we design a robust microfluidic model of the TME to study CAF 
behavior.  Techniques for assessing collagen fiber alignment and hydraulic permeability are also 
presented here.  While this project works primarily with PDAC fibroblasts, this platform can be 
extended for use with all solid tumor types. 
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Materials and Methods 
Building a 3D Microfluidic Model of the Tumor Stroma 
The first step in developing our physiological model of the tumor stroma was to fabricate the 
microfluidic device.  The silicon master wafer was created using photolithography, and standard 
soft lithography techniques were used to mold the micro-devices12. This process is illustrated in 
Figure 1. The starting silicon wafer was coated in negative photoresist (SU-8) and selectively 
exposed to UV light in the specific target geometry.  The UV light crosslinked the material and 
created positive relief features in our desired design.  PDMS was then poured over the master, 
degassed, and cured overnight. The PDMS micro-devices were then cut out, and the ports were 
created using a 4 mm biopsy punch.  To finalize fabrication, the devices were irreversibly sealed 
to glass slides using plasma treatment. The final device geometry was a single straight channel (L 
– 5 mm, H – 1 mm, W – 0.5 mm). 
 
Figure 1: Photo- and soft lithography processes for device fabrication.  A silicon master is generated using SU-8 
photolithography techniques.  PDMS is then poured on the master to create device molds, which are then sealed to a glass 
slide. Device geometry is a straight channel (L- 5mm, W – 500 µm, H – 1mm) with 4mm inlet and outlet ports. 
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  To complete construction of our tumor stroma model, CAF embedded collagen gels were 
injected into the PDMS micro-devices.  However, prior to injection, each channel was coated with 
fibronectin (100 µg/ml) for 30 min at 37°C. Following fibronectin treatment, the collagen gel 
solutions were prepared. Rat tail collagen type I 
solutions (final concentrations of 6 or 3 mg/ml) were 
mixed at 4°C with CAF suspended media for a final cell 
concentration of 1800 cells/µL. These collagen-CAF 
solutions were injected into the micro-channels and 
allowed to polymerize at 37°C. This process has been 
described in further detail previously13. Both PTEN 
deleted (shPTEN) and wildtype (shnc) CAFs were 
utilized in this project, and these cells – provided by Dr. 
Mike Ostrowski – were isolated from PDAC patients.  
PTEN expression was knocked down in these CAFs 
using shRNA to probe the effect of this genetic ablation. 
The final tumor stroma model can be seen in Figure 2. 
 
Measuring Collagen Fiber Alignment 
Collagen fiber alignment was measured using Fast Fourier Transform (FFT) analysis.  This 
technique was originally used to quantify woven fiber orientation in the textile industry14, but it 
has recently been exploited for measuring alignment of collagen15.  The FFT operates by 
converting image data from the spatial domain to the frequency domain.  This transformation 
 
Figure 2: CAF (red) containing 3D collagen 
(green) gels are injected into the PDMS micro-
channel (red square).  A pipet tip is inserted into 
the inlet port to impart a known pressure head for 
quantification of hydraulic permeability. 
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results in a power spectrum being obtained.  Next, a radial scan of the power spectrum can be used 
to obtain a frequency plot of all the collagen fibers in the image.  Figure 3 shows this process.  
 
Figure 3: Reflectance microscopy images of collagen fibers are analyzed in MATLAB.  The FFT calculation converts the 
original image to a power spectrum which can be analyzed mathematically.  The orientation plot shows the frequency of 
occurrence for each fiber in the original image.  The shaded area of the plot represents the aligned region of the image (± 20 
degrees from the dominant angle). 
 All collagen images were obtained using reflectance microscopy, and the FFT analysis was 
performed using a MATLAB algorithm.  This program was designed to automatically measure 
fiber alignment for all available image – thus providing our lab with a robust analysis technique. 
To compare results between samples, an alignment index was measured.  This metric is calculated 
by summing the frequencies in the most aligned region of the image and comparing this sum to 
the ideally random case as a ratio.  Therefore, a value of 1 indicates that the collagen fibers are 
completely random, and higher alignment indices are indicative of greater alignment. 
   
Quantifying Hydraulic Permeability 
To measure hydraulic permeability of our tumor stroma model, a pipet tip was cut (~2 cm) and 
inserted into the inlet port.  This design is shown in Figure 2.  The pipet tip allowed for the 
application of a pressure difference across the micro-channel by filling the tip with culture media.  
Moreover, a rhodamine-bovine serum albumin (rhodamine-BSA) dye was flowed into the micro-
device.  The movement of this fluorescent dye was tracked using time-lapse microscopy, and after 
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plotting the dye position over time, the flow speed within the channel was obtained.  This process 
is shown in Figure 4 below.  
 
Figure 4: A known pressure difference is applied across the microfluidic channel.  This pressure allows fluorescent dye to be 
flowed across the channel, and the movement can be tracked using time-lapse microscopy.  Using the flow speed calculated 
from these videos, a hydraulic permeability (K) value can be found using Darcy’s Law. Modified from Hammer et al.13 
 The flow speed (v) was then used in Darcy’s Law to calculate hydraulic permeability.  The 
height of media added to the pipet tip was used to find the applied pressure (P), and the channel 
length of 5 mm was known for our device.  The viscosity (µ) of the cell culture media was assumed 
to be water.  Darcy’s Law is also shown in Figure 4.  
 
Therapeutic Testing in Microfluidic TME Model 
The effect of different therapeutics on TME properties were also tested in our in vitro system. Each 
drug was supplemented into the culture media used to maintain the CAFs in the devices. First, 
Vismodegib (GDC-0449)16, a hedgehog pathway inhibitor, was tested.  GDC-0449 was 
supplemented into the cell culture medium at a concentration of 80 µM.  Next, an AKT-inhibitor 
(MK2206) was tested at 4.5 µM.  Previous research conducted by our collaborators has shown that 
PTEN deletion increases activity of p-AKT4, and we hypothesized that its upregulated occurrence 
could be contributing to the negative effects observed in the absence of PTEN. Finally, the effect 
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of hyaluronidase was also tested in our system.  Based on our preliminary results, we hypothesized 
that PTEN deleted CAFs could be secreting excess amounts of hyaluronan into their surrounding 
TME.  By applying hyaluronidase at 0.5 mg/ml, enzymatic degradation of HA was tested as a 
therapeutic strategy. For all three drug conditions, hydraulic permeability measurements were 
recorded.  This data was collected after 48 hours to allow time for the CAFs to remodel their 
microenvironment.  Moreover, the drug supplemented media was applied to acellular collagen gels 
as a control, and hydraulic permeability measurements were also performed on these samples. 
 
Acellular Collagen Gel Studies 
In addition to our study on CAFs, control experiments with acellular collagen were also performed.  
Acellular collagen gels were supplemented with HA or a crosslinking agent to test their effects on 
matrix architecture and hydraulic permeability.  To add HA to our collagen gels, a 5 mg/ml stock 
was diluted with the collagen solution to reach final concentrations of 0.5, 1.0, and 1.5 mg/ml HA.  
This procedure was done for both 3 and 6 mg/ml collagen solutions.  To crosslink the collagen 
gels, transglutaminase II was added to the collagen gel as 10% of the final volume.  These gels 
were then injected into the micro-channels and maintained for 48 hours before imaging and 
measuring hydraulic permeability. 
 
Statistical Analysis 
For this project, each test was performed on a minimum of three separate instances to ensure 
repeatability of our experiments and provide sufficient statistical power.  All statistical tests were 
conducted in JMP.  Collected data was analyzed using a one-way Analysis of Variance (ANOVA) 
and Tukey HSD post-testing with an α-level of 0.05.  
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Results and Discussion 
PTEN Deletion Lowers Hydraulic Permeability Without Collagen Fiber Rearrangement 
The first experiments performed investigated the effect of PTEN ablation on matrix properties.  As 
previously described, hydraulic permeability measurements were taken in our microfluidic model, 
and a significant decrease in hydraulic permeability was observed due to PTEN deletion.  These 
results can be seen in Figure 5. 
 
Figure 5: A significant decrease in hydraulic permeability was observed with PTEN deletion.  The permeability of the acellular 
gels was not significantly different than the shnc condition. Error bars represent standard deviations. 
This observed result could be a potential mechanism that allows tumors to increase their 
therapeutic resistance in the absence of PTEN.  The lowered permeability of PTEN deleted tumors 
could lead to poor penetration of anti-tumor agents into tumors.  To elucidate the specific 
microenvironmental changes that cause this decreased permeability, the collagen architecture of 
these gels was analyzed.  We hypothesized that PTEN deleted CAFs would remodel their 
surrounding environment to have more aligned fibers in comparison to the shnc and acellular 
conditions. 
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 Reflectance microscopy images were analyzed using FFT to quantify collagen fiber 
alignment.  No significant difference was found between the acellular collagen gel and either CAF 
condition, which does not support with our initial hypothesis.  Within our microfluidic model, the 
CAFs do not appear to rearrange fibers into an aligned structure.  Figure 6 displays these results. 
 
Figure 6: No significant differences in pore size or fiber alignment were seen within our microfluidic TME model. 
 Moreover, the pore sizes of our collagen images were also analyzed using the nearest-
obstacle distance (NOD) technique17.  Again, no significant difference in pore size (Figure 6) was 
seen between any of the experimental conditions.  Combining all results from this portion of the 
project, shPTEN CAFs appear to lower hydraulic permeability of the TME independent of physical 
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rearrangement of collagen fibers.  Therefore, we then proposed that shPTEN CAFs may lower the 
permeability of the TME via enhanced secretion of ECM molecules. 
 
Hyaluronidase and MK2206 Recover Decreased Hydraulic Permeability 
Two drugs were chosen as potential methods to alleviate the decreased hydraulic permeability seen 
in the absence of PTEN.  Hyaluronidase (HAdase) was chosen as a method to degrade extracellular 
HA, whereas MK2206 would work intracellularly to inhibit HA production.  As previously 
described, both CAF types were maintained in drug supplemented media, and hydraulic 
permeability was measured.  These results are shown in Figure 7. 
 
Figure 7: The effect of hyaluronidase and MK2206 on hydraulic permeability was investigated within our microfluidic system.  
Significant increases in hydraulic permeability were seen for the shPTEN CAFs when the drugs were applied.  Acellular gels 
with both drugs applied were also tested.  These controls were not significantly different, and their mean permeability is 
represented by the blue dotted line. 
 Both HAdase and MK2206 significantly increased the hydraulic permeability of the 
shPTEN embedded collagen gels to levels comparable to the acellular controls and shnc gels.  In 
contrast, only application of HAdase had a significant effect on the hydraulic permeability of the 
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shnc gels; these shnc CAFs are still able to secrete HA which may explain the observed result.  
Overall, this study shows potential for the use of HAdase and MK2206 to reduce therapeutic 
resistance in solid tumors where PTEN is diminished in stromal fibroblasts.  Used in combination 
with an anti-tumor agent, these two therapeutics could increase treatment efficacy. 
 
GDC-0449 Lowers Hydraulic Permeability of Wildtype CAFs 
In addition to utilizing our microsystem to develop new stromal targeted therapies, this platform 
can also be used to test the effect of anti-tumor agents on the TME.  Our system could identify 
whether a cancer therapeutic negatively affects the tumor stroma.  One drug that we tested was 
GDC-0449. This therapeutic has been shown by the Ostrowski lab to result in the undesired effect 
of reducing PTEN expression in CAFs.  To test whether this GDC-0449 induced PTEN deletion 
also negatively affects the physical properties of the TME, we performed hydraulic permeability 
assays within our system – results shown in Figure 8. 
 
Figure 8: GDC-0449 significantly decreases the hydraulic permeability of shnc embedded collagen gels. 
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As expected, the application of GDC-0449 to shnc collagen gels caused decreased 
hydraulic permeability.  The shnc+GDC-0449 condition resulted in permeability values 
comparable to shPTEN.  Moreover, the addition of GDC-0449 to the acellular and shPTEN 
collagen gels did not cause any significant changes. 
This reduction in hydraulic permeability after applying GDC-0449 could help to explain 
why this drug ultimately failed in clinical trials.  GDC-0449 appears to negatively affect the 
properties of the TME by silencing PTEN expression.  Furthermore, this result validates our belief 
that PTEN deletion in CAFs is the cause of decreased hydraulic permeability. 
 
Acellular Collagen Gel Results 
Acellular gels were modified via collagen crosslinking and HA addition in this project.  These 
studies were performed to examine whether specific properties of the collagen matrix could be 
modulated.  Pore size and alignment index data is shown in Figure 9. As previously stated, 3.0 
and 6.0 mg/ml collagen gels were used.  Significant increases in pore size were observed for all 
three HA concentrations at both collagen concentrations.  This finding can possibly be explained 
by the ability for HA to absorb water and swell.  The swollen HA could potentially displace the 
collagen fibers and result in the larger observed pore size.  Crosslinking of the collagen gels did 
not result in statistically significant changes in pore size. 
 For the fiber alignment results, no significant difference was observed between the 6.0 
mg/ml control and the other conditions.  However, at 3.0 mg/ml collagen, a significant difference 
in alignment index was seen between the control and crosslinked condition.  One possible 
explanation for this result is the lower collagen concentration could have reduced steric hindrance 
to allow the fibers to align more readily. 
18 
 
 
 
Figure 9: The addition of HA to both 3.0 and 6.0 mg/ml collagen gels causes significant increases in pore size.  A significant 
difference in fiber alignment between the 3.0 mg/ml control and 0.5 mg/ml condition was seen. Error bars represent standard 
deviation.  
 Hydraulic permeability measurements were also performed on our acellular gels.  Figure 
10 displays these results.  Interestingly, the only significant change observed was between the 
crosslinked and control 3.0 mg/ml collagen gels.  The addition of HA did not appear to decrease 
hydraulic permeability.  This finding seems contradictory to our CAF data where the secretion of 
HA caused decreased permeability.  However, the microarchitecture analysis can be used to 
explain this discrepancy.  In our acellular studies, HA addition caused increases in pore size – an 
effect which is not observed in our cell studies.  HA addition and pore size increase may have 
competing influences on hydraulic permeability in our acellular study.  Contrarily, HA secretion 
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occurs without pore size increase in the CAF study which may allow the changes in hydraulic 
permeability to be observed. 
 The findings from this study highlight an important difference between HA 
supplementation to collagen gels and CAF secreted HA.  In other words, simple addition of HA to 
the collagen gels may not be sufficient in reproducing the high HA content from PTEN deleted 
CAFs in in vivo tumors.    
 
Figure 10: The only significant difference in hydraulic permeability was observed between the crosslinked and control 3.0 
mg/ml collagen conditions.  HA addition does not appear to affect hydraulic permeability within our acellular gels. 
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Conclusions and Future Work 
Using microfluidic techniques, we have developed a micro-physiological model of the TME.  This 
system – containing CAFs embedded within a collagen hydrogel – allows examination of CAF-
mediated changes in matrix properties and the effect of therapeutics on the TME.  First, we found 
that PTEN deletion in CAFs causes significantly decreased hydraulic permeability.  This 
occurrence can be used to explain the increased tumor aggression in the absence of PTEN. In this 
project, both hyaluronidase and MK2206 have been identified as potential therapeutic approaches 
to restore the lowered hydraulic permeability in PTEN deleted CAFs.  Combined with an anti-
tumor agent, these therapies could increase the efficiency of treatment.  Moreover, our system has 
shown that GDC-0449 causes decreases in hydraulic permeability that reproduce the phenotypes 
observed with PTEN deleted CAFs. 
 Future studies may begin to investigate the crosstalk that occurs between cancer cells and 
the TME.  The introduction of conditioned media or cancer cells into our system could provide 
profound insights into the communication present between cancer cells and CAFs.  Moreover, we 
plan to study how additional therapeutics, such as a crosslink inhibitor, affect the properties of the 
TME. 
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